Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Germany's foreign intelligence service in 2020 put at 80%-90% the likelihood that the coronavirus behind the COVID-19 ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Like many anxious parents, Beth Spektor spent the last few weeks fretting over how to protect her infant daughter from the ...

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden ...